Armistice Capital’s Sunshine Biopharma SBFM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-5
Closed -$578K – 403
2023
Q4
$578K Buy
5
+3
+150% +$341K 0.01% 195
2023
Q3
$312K Sell
2
-3
-60% -$537K ﹤0.01% 181
2023
Q2
$1.08M Buy
+5
New +$1.21M 0.02% 159
2022
Q2
– Sell
-2
Closed -$1.56M – 198
2022
Q1
$1.56M Buy
+2
New +$1.95M 0.03% 103

Other funds holding SBFM

Armistice Capital's SBFM Position: Q1 2024 in Review

Armistice Capital sold out of Sunshine Biopharma (SBFM) in Q1 2024, closing a stake of 5 shares — an estimated $578K sold.

Armistice Capital first reported a position in SBFM in Q1 2022 and held it in 4 quarters. The position peaked at $1.56M in Q1 2022. 3 funds tracked by Wall St. Rank hold SBFM as of Q1 2024.

  • Armistice Capital reported no remaining Sunshine Biopharma position as of Q1 2024 after selling out during the quarter.
  • Armistice Capital sold 5 Sunshine Biopharma shares in Q1 2024, an estimated $578K.
  • Armistice Capital first reported a position in Sunshine Biopharma in Q1 2022 and held it in 4 quarters.
  • Armistice Capital's Sunshine Biopharma position peaked at $1.56M in Q1 2022.
  • 3 funds tracked by Wall St. Rank held Sunshine Biopharma as of Q1 2024.

Based on Armistice Capital's 13F filing for Q1 2024, filed 15 May 2024.